{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:24:29Z","timestamp":1791170669599,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/nrendo.2014.193","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T08:17:12Z","timestamp":1415089032000},"page":"708-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mortality in acromegaly reduced with multimodal therapy"],"prefix":"10.1038","volume":"10","author":[{"given":"Nienke R.","family":"Biermasz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"BFnrendo2014193_CR1","doi-asserted-by":"publisher","unstructured":"Mercado, M.  et al. Successful mortality reduction and control of co-morbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J. Clin. Endocrinol. Metab. \n                    http:\/\/press.endocrine.org\/doi\/abs\/10.1210\/jc.2014-2670\n                    \n                  .","DOI":"10.1210\/jc.2014-2670"},{"key":"BFnrendo2014193_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A. & Vandenbroucke, J. P. Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 61\u201367 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2014193_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway I. M., Bolland M. J. & Gamble G. D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159, 89\u201395 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2014193_CR4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","volume":"31","author":"M Sherlock","year":"2010","unstructured":"Sherlock, M.  et al. Mortality in patients with pituitary disease. Endocr. Rev. 31, 301\u2013342 (2010).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2014193_CR5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","volume":"94","author":"S Melmed","year":"2009","unstructured":"Melmed S.  et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509\u20131517 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2014193_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EJE-13-0166","volume":"169","author":"F Bogazzi","year":"2013","unstructured":"Bogazzi F.  et al. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur. J. Endocrinol. 169, 367\u2013376 (2013).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2014193_CR7","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"Biermasz N. R.  et al. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J. Clin. Endocrinol. Metab. 89, 2789\u20132796 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2014193_CR8","first-page":"3419","volume":"83","author":"B Swearingen","year":"1998","unstructured":"Swearingen B.  et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 83, 3419\u20133426 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2014193_CR9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1210\/jc.2013-2450","volume":"99","author":"M Sherlock","year":"2014","unstructured":"Sherlock, M.  et al. A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk. J. Clin. Endocrinol. Metab. 99, 478\u2013485 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2014193_CR10","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1210\/jc.2011-1377","volume":"96","author":"AM Burgers","year":"2011","unstructured":"Burgers, A. M.  et al. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J. Clin. Endocrinol. Metab. 96, 2912\u20132920 (2011).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2014.193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2014.193","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2014.193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:44:00Z","timestamp":1684467840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2014.193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["BFnrendo2014193"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2014.193","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]},"assertion":[{"value":"4 November 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}